Skip to main content
Clinical Trials/CTRI/2015/04/005685
CTRI/2015/04/005685
Completed
未知

To Study The Utility Of Non-Invasive Spectrophotometric Hemoglobin (SpHb) Monitoring During Major Oncological Surgeries.

Rajiv Gandhi Cancer Institute0 sites50 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- patients undergoing major oncological surgeries involving major blood loss
Sponsor
Rajiv Gandhi Cancer Institute
Enrollment
50
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • ASA Grade I, II, III patient undergoing major elective oncosurgeries with expected blood loss more than 20% of blood volume

Exclusion Criteria

  • \- Patient with known Hemoglobinopathies, arrhythmias, severe hypotension.
  • \- Peripheral Vascular disease like Raynaudâ??s disease.
  • \- Any skin abnormalities affecting the digits.
  • \- Patient on antipsychotic drugs and patient having high total bilirubin levels.

Outcomes

Primary Outcomes

Not specified

Similar Trials